The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Samsung Epis Holdings, the new holding company for Samsung Bioepis, is pursuing a bold expansion strategy focused on pipeline ...

The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon ...

J&J, having already announced several manufacturing investments in North Carolina, has announced another one: a new drug ...

The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced that they have entered into a collaboration and license agreement to pursue ...

Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 ...

Loyal’s application for drug approval is another step closer to potential approval through the FDA Center for Veterinary ...

Eli Lilly's research and development head said on Monday the company will have plenty of supply to launch its ...

Researchers decipher the function of an ion channel involved in cellular degradation processes and create new possibilities for Parkinson's ...

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...